EUVIMEDEUVIMED entdecken
Crossref

Development of Anti-multiple Myeloma Agents Targeting Adenosine Monophosphate Deaminase 1

Takuya Kobayakawa, Eric Coffie, Yawara Kawano, Kohei Tsuji, Miyuki Nakayama, Masao Matsuoka, Hirokazu Tamamura

Chemical and Pharmaceutical Bulletin · 20.11.2026 · 74 (11) · 870-876

DOI: 10.1248/cpb.c26-00503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, erschienen am 20.11.2026. Verfasst von Takuya Kobayakawa und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although several anti-multiple myeloma (MM) drugs have been developed to improve the prognosis of its patients, MM is still an incurable disease. At present, the development of new therapeutic agents that are highly specific to MM cells and have action mechanisms different from those of the existing drugs is highly required. As important candidates, molecules that target AMP deaminase 1 (AMPD1), which is specifically expressed in plasma cells and MM cells, might be novel agents for MM therapy. Here, we report the design, synthesis, and evaluation of new AMPD1 inhibitors based on reported AMPD1 inhibitors. These results, including their structure–activity relationships, should provide useful information for further development of therapeutic agents for MM patients.

Zitieren

APA

Kobayakawa, T., Coffie, E., Kawano, Y., Tsuji, K., Nakayama, M., Matsuoka, M., & Tamamura, H. (2026). Development of Anti-multiple Myeloma Agents Targeting Adenosine Monophosphate Deaminase 1. Chemical and Pharmaceutical Bulletin, 74(11), 870-876. https://doi.org/10.1248/cpb.c26-00503

Vancouver

Kobayakawa T, Coffie E, Kawano Y, Tsuji K, Nakayama M, Matsuoka M, et al. Development of Anti-multiple Myeloma Agents Targeting Adenosine Monophosphate Deaminase 1. Chemical and Pharmaceutical Bulletin. 2026;74(11):870-876. doi:10.1248/cpb.c26-00503

BibTeX
@article{Kobayakawa2026,
  author = {Kobayakawa, Takuya and Coffie, Eric and Kawano, Yawara and Tsuji, Kohei and Nakayama, Miyuki and Matsuoka, Masao and Tamamura, Hirokazu},
  title = {Development of Anti-multiple Myeloma Agents Targeting Adenosine Monophosphate Deaminase 1},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2026},
  volume = {74},
  number = {11},
  pages = {870--876},
  doi = {10.1248/cpb.c26-00503}
}
Kostenlos starten →